Skip to content

Use of honey for the treatment of leprosy ulcer

Honey Experiment on LeProsy Ulcer (HELP): a randomised control trial of raw, unadulterated African honey for ulcer healing in leprosy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN10093277
Enrollment
130
Registered
2021-12-22
Start date
2022-02-15
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leprosy ulcer Infections and Infestations Leprosy [Hansen disease]

Interventions

Participants will be enrolled sequentially and randomly allocated (1:1) to undergo honey treatment or usual care with normal saline using a “digital sealed envelope” method. An allocation table will b

Sponsors

The Leprosy Mission Nigeria
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patients with a chronic foot ulcer of at least 6 weeks duration due to leprosy neuropathy 2. =18 years of age 3. Ulcer surface area between 2 and 20 cm² inclusive 4. Ulcer is clean, dry, and free from infection 5. Patient can provide informed consent

Exclusion criteria

Exclusion criteria: Patients will be excluded if: 1. Ulcer is less than 6 weeks from appearance 2. Less than 18 years of age 3. Ulcer surface area is less than 2 cm² or more than 20 cm² 4. Ulcer is infected or a diabetic foot ulcer 5. Patient declined to give consent

Design outcomes

Primary

MeasureTime frame
Assessed from ‘blindly’ examined photographs: 1. Rate of healing based on one observation per week until the ulcers are healed 2. Time to complete re-epithelisation (up to 84 days)

Secondary

MeasureTime frame
Long-term (6-month) end-points, measured using a physical examination of the treatment site: 1. Recurrence of treated ulcer 2. Appearance of a new ulcer 3. Anatomical changes in the limb Long-term endpoints will be measured using medical records at the time of follow up at 6 months from randomisation: 1. Days hospitalised prior to discharge and total (to include any readmission related to leprosy ulcers) by 6 months 2. Number of visits to any healthcare facility from discharge to the end of follow-up at 6 months

Countries

Nigeria

Contacts

Public ContactPaul Tsaku
tsakup@tlmnigeria.org+234 (0)7035425305

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026